| Year |
Citation |
Score |
| 2021 |
Saminathan H, Ghosh A, Zhang D, Song C, Jin H, Anantharam V, Kanthasamy A, Kanthasamy AG. Fyn Kinase-Mediated PKCδ Y311 Phosphorylation Induces Dopaminergic Degeneration in Cell Culture and Animal Models: Implications for the Identification of a New Pharmacological Target for Parkinson's Disease. Frontiers in Pharmacology. 12: 631375. PMID 33995031 DOI: 10.3389/fphar.2021.631375 |
0.638 |
|
| 2016 |
Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, ... Zhang DD, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 12: 1-222. PMID 26799652 DOI: 10.1080/15548627.2015.1100356 |
0.629 |
|
| 2016 |
Zhao M, Ren H, Chang J, Zhang D, Yang Y, He Y, Qi C, Zhang H. Design and synthesis of novel pyrazolo[1,5-a]pyrimidine derivatives bearing nitrogen mustard moiety and evaluation of their antitumor activity in vitro and in vivo European Journal of Medicinal Chemistry. 119: 183-196. DOI: 10.1021/jm00163a019 |
0.492 |
|
| 2016 |
Zhang H, Luo X, Ke J, Duan Y, He Y, Zhang D, Cai M, Sun G, Sun X. Procyanidins, from Castanea mollissima Bl. shell, induces autophagy following apoptosis associated with PI3K/AKT/mTOR inhibition in HepG2 cells Biomedicine and Pharmacotherapy. 81: 15-24. DOI: 10.1016/j.biopha.2016.04.002 |
0.323 |
|
| 2011 |
Zhang D, Kanthasamy A, Anantharam V, Kanthasamy A. Effects of manganese on tyrosine hydroxylase (TH) activity and TH-phosphorylation in a dopaminergic neural cell line. Toxicology and Applied Pharmacology. 254: 65-71. PMID 21310168 DOI: 10.1016/J.Taap.2010.03.023 |
0.654 |
|
| 2008 |
Sun F, Anantharam V, Jin H, Zhang D, Kanthasamy A, Kanthasamy AG. Neuroprotective and Neurotoxic Properties of α-Synuclein in Cell Culture Models of Dopaminergic Degeneration Parkinson's Disease. 475-490. DOI: 10.1016/B978-0-12-374028-1.00036-1 |
0.715 |
|
| 2007 |
Zhang D, Anantharam V, Kanthasamy A, Kanthasamy AG. Neuroprotective effect of protein kinase C delta inhibitor rottlerin in cell culture and animal models of Parkinson's disease. The Journal of Pharmacology and Experimental Therapeutics. 322: 913-22. PMID 17565007 DOI: 10.1124/Jpet.107.124669 |
0.718 |
|
| 2007 |
Zhang D, Kanthasamy A, Yang Y, Anantharam V, Kanthasamy A. Protein kinase C delta negatively regulates tyrosine hydroxylase activity and dopamine synthesis by enhancing protein phosphatase-2A activity in dopaminergic neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 5349-62. PMID 17507557 DOI: 10.1523/Jneurosci.4107-06.2007 |
0.704 |
|
| 2006 |
Kanthasamy AG, Anantharam V, Zhang D, Latchoumycandane C, Jin H, Kaul S, Kanthasamy A. A novel peptide inhibitor targeted to caspase-3 cleavage site of a proapoptotic kinase protein kinase C delta (PKCdelta) protects against dopaminergic neuronal degeneration in Parkinson's disease models. Free Radical Biology & Medicine. 41: 1578-89. PMID 17045926 DOI: 10.1016/J.Freeradbiomed.2006.08.016 |
0.727 |
|
| 2006 |
Sun F, Anantharam V, Zhang D, Latchoumycandane C, Kanthasamy A, Kanthasamy AG. Proteasome inhibitor MG-132 induces dopaminergic degeneration in cell culture and animal models. Neurotoxicology. 27: 807-15. PMID 16870259 DOI: 10.1016/J.Neuro.2006.06.006 |
0.737 |
|
| 2004 |
Yang Y, Kaul S, Zhang D, Anantharam V, Kanthasamy AG. Suppression of caspase-3-dependent proteolytic activation of protein kinase C delta by small interfering RNA prevents MPP+-induced dopaminergic degeneration. Molecular and Cellular Neurosciences. 25: 406-21. PMID 15033169 DOI: 10.1016/J.Mcn.2003.11.011 |
0.763 |
|
| Show low-probability matches. |